TY - JOUR AU - Vestbo, J. AU - Hurd, S. S. AU - Agusti, A. G. PY - 2013 DA - 2013// TI - Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary JO - Am J Respir Crit Care Med VL - 187 UR - https://doi.org/10.1164/rccm.201204-0596PP DO - 10.1164/rccm.201204-0596PP ID - Vestbo2013 ER - TY - BOOK PY - 2016 DA - 2016// TI - Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease ID - ref2 ER - TY - JOUR AU - Soriano, J. B. AU - Visick, G. T. AU - Muellerova, H. AU - Payvandi, N. AU - Hansell, A. L. PY - 2005 DA - 2005// TI - Patterns of comorbidities in newly diagnosed COPD and asthma in primary care JO - Chest VL - 128 UR - https://doi.org/10.1378/chest.128.4.2099 DO - 10.1378/chest.128.4.2099 ID - Soriano2005 ER - TY - JOUR AU - Price, D. AU - Brusselle, G. AU - Roche, N. AU - Freeman, D. AU - Chisholm, A. PY - 2015 DA - 2015// TI - Real-world research and its importance in respiratory medicine JO - Breathe (Sheffield, England) VL - 11 UR - https://doi.org/10.1183/20734735.015414 DO - 10.1183/20734735.015414 ID - Price2015 ER - TY - JOUR AU - Roche, N. AU - Reddel, H. K. AU - Agusti, A. PY - 2013 DA - 2013// TI - Integrating real-life studies in the global therapeutic research framework JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70199-1 DO - 10.1016/S2213-2600(13)70199-1 ID - Roche2013 ER - TY - JOUR AU - Halpin, D. M. PY - 2010 DA - 2010// TI - Lessons from the major studies in COPD: problems and pitfalls in translating research evidence into practice JO - Prim Care Respir J VL - 19 UR - https://doi.org/10.4104/pcrj.2010.00015 DO - 10.4104/pcrj.2010.00015 ID - Halpin2010 ER - TY - JOUR AU - Price, D. B. AU - Swern, A. AU - Tozzi, C. A. AU - Philip, G. AU - Polos, P. PY - 2006 DA - 2006// TI - Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial JO - Allergy VL - 61 UR - https://doi.org/10.1111/j.1398-9995.2006.01007.x DO - 10.1111/j.1398-9995.2006.01007.x ID - Price2006 ER - TY - JOUR AU - Roche, N. AU - Reddel, H. AU - Martin, R. PY - 2014 DA - 2014// TI - Quality standards for real-world research. Focus on observational database studies of comparative effectiveness JO - Ann Am Thorac Soc VL - 11 UR - https://doi.org/10.1513/AnnalsATS.201309-300RM DO - 10.1513/AnnalsATS.201309-300RM ID - Roche2014 ER - TY - BOOK AU - Morris, J. N. PY - 1975 DA - 1975// TI - Uses of epidemiology PB - Churchill Livingstone CY - Edinburgh ID - Morris1975 ER - TY - STD TI - (NICE) NIfHaCE. Chronic obstructive pulmonary disease. 2010. http://cks.nice.org.uk/chronic-obstructive-pulmonary-disease (accessed 01 Oct 2015). UR - http://cks.nice.org.uk/chronic-obstructive-pulmonary-disease ID - ref10 ER - TY - JOUR AU - Vestbo, J. AU - Anderson, J. AU - Brook, R. D. PY - 2013 DA - 2013// TI - The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol JO - Eur Respir J VL - 41 UR - https://doi.org/10.1183/09031936.00087312 DO - 10.1183/09031936.00087312 ID - Vestbo2013 ER - TY - JOUR AU - Tashkin, D. P. AU - Celli, B. AU - Senn, S. PY - 2008 DA - 2008// TI - A 4-year trial of tiotropium in chronic obstructive pulmonary disease JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0805800 DO - 10.1056/NEJMoa0805800 ID - Tashkin2008 ER - TY - JOUR AU - Wu, A. C. AU - Butler, M. G. AU - Li, L. PY - 2015 DA - 2015// TI - Primary adherence to controller medications for asthma is poor JO - Ann Am Thorac Soc VL - 12 UR - https://doi.org/10.1513/AnnalsATS.201410-459OC DO - 10.1513/AnnalsATS.201410-459OC ID - Wu2015 ER - TY - JOUR AU - Sadatsafavi, M. AU - FitzGerald, M. AU - Marra, C. AU - Lynd, L. PY - 2013 DA - 2013// TI - Costs and health outcomes associated with primary vs secondary care after an asthma-related hospitalization: a population-based study JO - Chest VL - 144 UR - https://doi.org/10.1378/chest.12-2773 DO - 10.1378/chest.12-2773 ID - Sadatsafavi2013 ER - TY - JOUR AU - Holgate, S. T. AU - Price, D. AU - Valovirta, E. PY - 2006 DA - 2006// TI - Asthma out of control? A structured review of recent patient surveys JO - BMC Pulm Med VL - 6 UR - https://doi.org/10.1186/1471-2466-6-S1-S2 DO - 10.1186/1471-2466-6-S1-S2 ID - Holgate2006 ER - TY - JOUR AU - Travers, J. AU - Marsh, S. AU - Caldwell, B. PY - 2007 DA - 2007// TI - External validity of randomized controlled trials in COPD JO - Respir Med VL - 101 UR - https://doi.org/10.1016/j.rmed.2006.10.011 DO - 10.1016/j.rmed.2006.10.011 ID - Travers2007 ER - TY - JOUR AU - Treweek, S. AU - Zwarenstein, M. PY - 2009 DA - 2009// TI - Making trials matter: pragmatic and explanatory trials and the problem of applicability JO - Trials VL - 10 UR - https://doi.org/10.1186/1745-6215-10-37 DO - 10.1186/1745-6215-10-37 ID - Treweek2009 ER - TY - JOUR AU - Jones, R. AU - Jones, R. O. AU - McCowan, C. AU - Montgomery, A. A. AU - Fahey, T. PY - 2009 DA - 2009// TI - The external validity of published randomized controlled trials in primary care JO - BMC Fam Pract VL - 10 UR - https://doi.org/10.1186/1471-2296-10-5 DO - 10.1186/1471-2296-10-5 ID - Jones2009 ER - TY - JOUR AU - Herland, K. AU - Akselsen, J. P. AU - Skjonsberg, O. H. AU - Bjermer, L. PY - 2005 DA - 2005// TI - How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? JO - Respir Med VL - 99 UR - https://doi.org/10.1016/j.rmed.2004.03.026 DO - 10.1016/j.rmed.2004.03.026 ID - Herland2005 ER - TY - JOUR AU - Kruis, A. L. AU - Stallberg, B. AU - Jones, R. C. PY - 2014 DA - 2014// TI - Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0090145 DO - 10.1371/journal.pone.0090145 ID - Kruis2014 ER - TY - JOUR AU - Walker, S. AU - Fingleton, J. AU - Weatherall, M. AU - Beasley, R. PY - 2013 DA - 2013// TI - Limited generalisability of UPLIFT findings to clinical practice JO - Thorax VL - 68 UR - https://doi.org/10.1136/thoraxjnl-2013-203724 DO - 10.1136/thoraxjnl-2013-203724 ID - Walker2013 ER - TY - JOUR AU - Scichilone, N. AU - Basile, M. AU - Battaglia, S. AU - Bellia, V. PY - 2014 DA - 2014// TI - What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials? JO - Respiration VL - 87 UR - https://doi.org/10.1159/000355082 DO - 10.1159/000355082 ID - Scichilone2014 ER - TY - JOUR AU - Altman, D. G. AU - Royston, J. P. PY - 1988 DA - 1988// TI - The hidden effect of time JO - Stat Med VL - 7 UR - https://doi.org/10.1002/sim.4780070602 DO - 10.1002/sim.4780070602 ID - Altman1988 ER - TY - STD TI - Optimum Patient Care Research Database (OPCRD). 2015. http://optimumpatientcare.org/our-database/ (accessed 17 Aug 2015). UR - http://optimumpatientcare.org/our-database/ ID - ref24 ER - TY - JOUR AU - Wedzicha, J. A. AU - Decramer, M. AU - Ficker, J. H. PY - 2013 DA - 2013// TI - Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70052-3 DO - 10.1016/S2213-2600(13)70052-3 ID - Wedzicha2013 ER - TY - STD TI - ClinicalTrials.gov. QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study. 02/06/2014. https://clinicaltrials.gov/ct2/show/NCT01782326?term=NCT01782326&rank=1 (accessed 10 Feb 2016). UR - https://clinicaltrials.gov/ct2/show/NCT01782326?term=NCT01782326&rank=1 ID - ref26 ER - TY - JOUR AU - Dusser, D. AU - Bravo, M. L. AU - Iacono, P. PY - 2006 DA - 2006// TI - The effect of tiotropium on exacerbations and airflow in patients with COPD JO - Eur Respir J VL - 27 UR - https://doi.org/10.1183/09031936.06.00062705 DO - 10.1183/09031936.06.00062705 ID - Dusser2006 ER - TY - JOUR AU - Ferguson, G. T. AU - Feldman, G. J. AU - Hofbauer, P. PY - 2014 DA - 2014// TI - Efficacy and safety of olodaterol once daily delivered via Respimat(R) in patients with GOLD 2–4 COPD: results from two replicate 48-week studies JO - Int J Chron Obstruct Pulmon Dis VL - 9 UR - https://doi.org/10.2147/COPD.S61717 DO - 10.2147/COPD.S61717 ID - Ferguson2014 ER - TY - JOUR AU - Koch, A. AU - Pizzichini, E. AU - Hamilton, A. PY - 2014 DA - 2014// TI - Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat(R) versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studies JO - Int J Chron Obstruct Pulmon Dis VL - 9 UR - https://doi.org/10.2147/COPD.S62502 DO - 10.2147/COPD.S62502 ID - Koch2014 ER - TY - JOUR AU - Buhl, R. AU - Maltais, F. AU - Abrahams, R. PY - 2015 DA - 2015// TI - Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4) JO - Eur Respir J VL - 45 UR - https://doi.org/10.1183/09031936.00136014 DO - 10.1183/09031936.00136014 ID - Buhl2015 ER - TY - STD TI - (HSCIC) HSCIC. Quality and Outomes Framework (QOF). http://www.hscic.gov.uk/qof (accessed 08 Oct 2015). UR - http://www.hscic.gov.uk/qof ID - ref31 ER - TY - JOUR AU - Donohue, J. F. AU - Noord, J. A. AU - Bateman, E. D. PY - 2002 DA - 2002// TI - A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol JO - Chest VL - 122 UR - https://doi.org/10.1378/chest.122.1.47 DO - 10.1378/chest.122.1.47 ID - Donohue2002 ER - TY - JOUR AU - Niewoehner, D. E. AU - Rice, K. AU - Cote, C. PY - 2005 DA - 2005// TI - Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial JO - Ann Intern Med VL - 143 UR - https://doi.org/10.7326/0003-4819-143-5-200509060-00007 DO - 10.7326/0003-4819-143-5-200509060-00007 ID - Niewoehner2005 ER - TY - JOUR AU - Chan, C. K. AU - Maltais, F. AU - Sigouin, C. AU - Haddon, J. M. AU - Ford, G. T. PY - 2007 DA - 2007// TI - A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease JO - Can Respir J VL - 14 UR - https://doi.org/10.1155/2007/192961 DO - 10.1155/2007/192961 ID - Chan2007 ER - TY - JOUR AU - Bateman, E. D. AU - Tashkin, D. AU - Siafakas, N. PY - 2010 DA - 2010// TI - A one-year trial of tiotropium Respimat plus usual therapy in COPD patients JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2010.06.004 DO - 10.1016/j.rmed.2010.06.004 ID - Bateman2010 ER - TY - JOUR AU - Vogelmeier, C. AU - Hederer, B. AU - Glaab, T. PY - 2011 DA - 2011// TI - Tiotropium versus salmeterol for the prevention of exacerbations of COPD JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1008378 DO - 10.1056/NEJMoa1008378 ID - Vogelmeier2011 ER - TY - JOUR AU - Wise, R. A. AU - Anzueto, A. AU - Cotton, D. PY - 2013 DA - 2013// TI - Tiotropium Respimat inhaler and the risk of death in COPD JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1303342 DO - 10.1056/NEJMoa1303342 ID - Wise2013 ER - TY - JOUR AU - Li, X. AU - Zhou, Y. AU - Chen, S. AU - Zheng, J. AU - Zhong, N. AU - Ran, P. PY - 2014 DA - 2014// TI - Early intervention with tiotropium in Chinese patients with GOLD stages I-II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial JO - BMJ Open VL - 4 UR - https://doi.org/10.1136/bmjopen-2013-003991 DO - 10.1136/bmjopen-2013-003991 ID - Li2014 ER - TY - JOUR AU - Vogelmeier, C. AU - Kardos, P. AU - Harari, S. AU - Gans, S. J. AU - Stenglein, S. AU - Thirlwell, J. PY - 2008 DA - 2008// TI - Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study JO - Respir Med VL - 102 UR - https://doi.org/10.1016/j.rmed.2008.07.020 DO - 10.1016/j.rmed.2008.07.020 ID - Vogelmeier2008 ER - TY - JOUR AU - Jones, P. W. AU - Rennard, S. I. AU - Agusti, A. PY - 2011 DA - 2011// TI - Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-55 DO - 10.1186/1465-9921-12-55 ID - Jones2011 ER - TY - JOUR AU - Jones, P. W. AU - Singh, D. AU - Bateman, E. D. PY - 2012 DA - 2012// TI - Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study JO - Eur Respir J VL - 40 UR - https://doi.org/10.1183/09031936.00225511 DO - 10.1183/09031936.00225511 ID - Jones2012 ER - TY - JOUR AU - Gelb, A. F. AU - Tashkin, D. P. AU - Make, B. J. AU - Zhong, X. AU - Garcia Gil, E. AU - Caracta, C. PY - 2013 DA - 2013// TI - Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.07.001 DO - 10.1016/j.rmed.2013.07.001 ID - Gelb2013 ER - TY - JOUR AU - Donohue, J. F. AU - Fogarty, C. AU - Lotvall, J. PY - 2010 DA - 2010// TI - Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium JO - Am J Respir Crit Care Med VL - 182 UR - https://doi.org/10.1164/rccm.200910-1500OC DO - 10.1164/rccm.200910-1500OC ID - Donohue2010 ER - TY - JOUR AU - Kornmann, O. AU - Dahl, R. AU - Centanni, S. PY - 2011 DA - 2011// TI - Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison JO - Eur Respir J VL - 37 UR - https://doi.org/10.1183/09031936.00045810 DO - 10.1183/09031936.00045810 ID - Kornmann2011 ER - TY - JOUR AU - Yao, W. AU - Wang, C. AU - Zhong, N. PY - 2014 DA - 2014// TI - Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study JO - Respirology (Carlton, Vic) VL - 19 UR - https://doi.org/10.1111/resp.12211 DO - 10.1111/resp.12211 ID - Yao2014 ER - TY - JOUR AU - Decramer, M. L. AU - Chapman, K. R. AU - Dahl, R. PY - 2013 DA - 2013// TI - Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70158-9 DO - 10.1016/S2213-2600(13)70158-9 ID - Decramer2013 ER - TY - JOUR AU - Kerwin, E. AU - Hebert, J. AU - Gallagher, N. PY - 2012 DA - 2012// TI - Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study JO - Eur Respir J VL - 40 UR - https://doi.org/10.1183/09031936.00040712 DO - 10.1183/09031936.00040712 ID - Kerwin2012 ER - TY - JOUR AU - D’Urzo, A. AU - Ferguson, G. T. AU - Noord, J. A. PY - 2011 DA - 2011// TI - Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-156 DO - 10.1186/1465-9921-12-156 ID - D’Urzo2011 ER - TY - JOUR AU - Wang, C. AU - Sun, T. AU - Huang, Y. PY - 2015 DA - 2015// TI - Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study JO - Int J Chron Obstruct Pulmon Dis VL - 10 ID - Wang2015 ER - TY - JOUR AU - Bateman, E. D. AU - Ferguson, G. T. AU - Barnes, N. PY - 2013 DA - 2013// TI - Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00200212 DO - 10.1183/09031936.00200212 ID - Bateman2013 ER - TY - JOUR AU - Vogelmeier, C. F. AU - Bateman, E. D. AU - Pallante, J. PY - 2013 DA - 2013// TI - Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(12)70052-8 DO - 10.1016/S2213-2600(12)70052-8 ID - Vogelmeier2013 ER - TY - JOUR AU - Zhong, N. AU - Wang, C. AU - Zhou, X. PY - 2015 DA - 2015// TI - LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD JO - Int J Chron Obstruct Pulmon Dis VL - 10 ID - Zhong2015 ER - TY - JOUR AU - Donohue, J. F. AU - Maleki-Yazdi, M. R. AU - Kilbride, S. AU - Mehta, R. AU - Kalberg, C. AU - Church, A. PY - 2013 DA - 2013// TI - Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.06.001 DO - 10.1016/j.rmed.2013.06.001 ID - Donohue2013 ER - TY - JOUR AU - Decramer, M. AU - Anzueto, A. AU - Kerwin, E. PY - 2014 DA - 2014// TI - Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70065-7 DO - 10.1016/S2213-2600(14)70065-7 ID - Decramer2014 ER - TY - JOUR AU - Maleki-Yazdi, M. R. AU - Kaelin, T. AU - Richard, N. AU - Zvarich, M. AU - Church, A. PY - 2014 DA - 2014// TI - Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial JO - Respir Med VL - 108 UR - https://doi.org/10.1016/j.rmed.2014.10.002 DO - 10.1016/j.rmed.2014.10.002 ID - Maleki-Yazdi2014 ER -